Our COO, Daichi Tanaka, became a member of the advisory board of Innovators Under 35 Japan operated by MIT Technology Review.

Our COO, Daichi Tanaka, has been appointed as a healthcare expert by Beyond next ventures.

Our COO, Tanaka, and our business manager, Akane, Launched the IoMD working group at the Japan Digital Therapeutics Association.

Our CSO, Hiroaki Kato, has been reappointed as a part-time lecturer at Yokohama City University.

Our CSO, Hiroaki Kato, has been reappointed as Visiting Associate Professor at Chiba University Hospital.

Our CSO, Hiroaki Kato, has been reappointed as Clinical Associate Professor of Tokyo Medical and Dental University.

Our CSO, Hiroaki Kato, has been reappointed as a part-time lecturer at Graduate School at Tohoku University.

Our CSO, Hiroaki Kato, has been re-elected as a councilor of the Japanese Ophthalmological AI Society.

Aillis ranked third in Nikkei Digital Health's ranking of the hottest venture companies in the digital health field.

Our CSO, Hiroaki Kato, has been appointed as a member of the Innovation Promotion Committee of the Japanese Ophthalmological Society.

Aillis moved to a new office.

Our CSO, Hiroaki Kato, published Iryo 4.0(Medical care 4.0) from Nikkei BP.

Aillis won AITC President Award at AI Business Idea Contest held by AIST and OCCI.